Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
July 18 2024 - 4:05PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2024
Commission file number: 001-40231
Universe Pharmaceuticals INC
265 Jingjiu Avenue
Jinggangshan Economic and Technological Development
Zone
Ji’an, Jiangxi, China 343100
+86-0796-8403309
(Address of principal executive offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
Closing of Public Offering
On July 15, 2024, Universe Pharmaceuticals
INC, a Cayman Islands company (the “Company”), closed its self-underwritten public offering (“Offering”) of 20,000,000
ordinary shares, par value $0.01875 per share (the “Ordinary Shares”). The Ordinary Shares were priced at $1.25 per share.
The Company raised a total of $25 million through this Offering, before deducting Offering-related expenses.
This report does not constitute
an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction
in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any
such state or jurisdiction.
SIGNATURES
Pursuant to the requirements of
the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
Universe Pharmaceuticals INC. |
|
|
Date: July 18, 2024 |
By: |
/s/ Gang Lai |
|
|
Gang Lai |
|
|
Chief Executive Officer |
Universe Pharmaceuticals (NASDAQ:UPC)
Historical Stock Chart
From Sep 2024 to Oct 2024
Universe Pharmaceuticals (NASDAQ:UPC)
Historical Stock Chart
From Oct 2023 to Oct 2024